


Clinical StrengthV.1.05
KPV 10mg Intranasal Spray
This 5mg formulation is utilized to study the foundational mechanisms of KPV, specifically its ability to translocate into the cell nucleus and inhibit pro-inflammatory signaling pathways like NF-$\kappa$B. It is an essential concentration for micro-dose titration in cellular models.
Recommended Sizes
102050
FormNasal Spray (Unit)
MOQ10
Lead Time14 Days
Shelf Life24 Mo.
Label Claims
- Standard purity claims apply.
Certification
GMPcGMP CERTIFIED
3rdLAB TESTED
Recommended Packaging
Default Packaging Load Active